Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaiser, N.
Right arrow Articles by Leibowitz, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaiser, N.
Right arrow Articles by Leibowitz, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:S137-S144, 2005
© 2005 by the American Diabetes Association, Inc.


Section IV: Polygenic Disease and Environment

Psammomys Obesus, a Model for Environment-Gene Interactions in Type 2 Diabetes

Nurit Kaiser1, Rafael Nesher1, Marc Y. Donath2, Merav Fraenkel1, Vered Behar3, Christophe Magnan4, Alain Ktorza5, Erol Cerasi1, and Gil Leibowitz1

1 Endocrinology and Metabolism Service, Department of Internal Medicine, and Hadassah Diabetes Center, Hebrew University-Hadassah Medical Center, Jerusalem, Israel
2 Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, Zurich, Switzerland
3 QuantomiX, Rehovot, Israel
4 Laboratoire de Physiopathologie de la Nutrition, Centre National de la Recherche Scientific (CNRS) Unite Mixte de Recherche (UMR) 7059, Paris, France
5 Institut de Recherches Servier (I.D.R.S.), Suresnes, France

Type 2 diabetes is characterized by insulin resistance and progressive ß-cell failure. Deficient insulin secretion, with increased proportions of insulin precursor molecules, is a common feature of type 2 diabetes; this could result from inappropriate ß-cell function and/or reduced ß-cell mass. Most studies using tissues from diabetic patients are retrospective, providing only limited information on the relative contribution of ß-cell dysfunction versus decreased ß-cell mass to the "ß-cell failure" of type 2 diabetes. The gerbil Psammomys obesus is a good model to address questions related to the role of insulin resistance and ß-cell failure in nutritionally induced diabetes. Upon a change from its natural low-calorie diet to the calorie-rich laboratory food, P. obesus develops moderate obesity associated with postprandial hyperglycemia. Continued dietary load, superimposed on its innate insulin resistance, results in depletion of pancreatic insulin stores, with increased proportions of insulin precursor molecules in the pancreas and the blood. Inadequate response of the preproinsulin gene to the increased insulin needs is an important cause of diabetes progression. Changes in ß-cell mass do not correlate with pancreatic insulin stores and are unlikely to play a role in disease initiation and progression. The major culprit is the inappropriate insulin production with depletion of insulin stores as a consequence. Similar mechanisms could operate during the evolution of type 2 diabetes in humans.


Address correspondence and reprint requests to Nurit Kaiser, PhD, Endocrinology and Metabolism Service, Hadassah University Hospital, P.O. Box 12000, 91120 Jerusalem, Israel. E-mail: kaiser{at}md.huji.ac.il

Abbreviations: DP, diabetes prone; DR, diabetes resistant; HE, high energy; LE, low energy; PDX-1, pancreatic duodenal homeobox-1


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav, O. Pappo, M. Karaca, J. Castel, M.-F. Berthault, C. Magnan, E. Cerasi, N. Kaiser, et al.
mTOR Inhibition by Rapamycin Prevents {beta}-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes
Diabetes, April 1, 2008; 57(4): 945 - 957.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.